Zhengye Biotechnology Holding Limited (ZYBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 2,549 | 3,741 |
| Marketable Securities | 197 | 168 |
| Receivables | 10,099 | 10,907 |
| Inventories | 7,977 | 8,022 |
| Income taxes - deferred | N/A | 1,639 |
| Other current assets | 3,506 | 3,813 |
| TOTAL | $24,328 | $28,290 |
| Non-Current Assets | ||
| PPE Net | 34,957 | 36,224 |
| Intangibles | 3,121 | 3,370 |
| Other Non-Current Assets | 5,171 | 903 |
| TOTAL | $43,249 | $40,497 |
| Total Assets | $67,577 | $68,787 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 11,184 | 10,989 |
| Accounts payable and accrued liabilities | 5,905 | 6,282 |
| Accrued Expenses | 769 | 397 |
| Other current liabilities | 477 | 535 |
| TOTAL | $18,618 | $20,673 |
| Non-Current Liabilities | ||
| Long Term Debt | 658 | 1,375 |
| Other Non-Current Liabilities | -296 | -779 |
| TOTAL | $658 | $1,429 |
| Total Liabilities | $19,276 | $22,102 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | 6,597 | 5,281 |
| Other shareholders' equity | 13,871 | 13,449 |
| TOTAL | $48,301 | $46,685 |
| Total Liabilities And Equity | $67,577 | $68,787 |